Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China

References

• van Duin D, Arias CA, Komarow L, et al. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis. 2020;20(6):731–741. doi:10.1016/S1473-3099(19)30755-8
   PubMed Web of Science ®Google Scholar
• Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610. doi:10.1016/S1473-3099(18)30792-8
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): November 2015 Update - CRE Toolkit. 2015. Available at https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. Accessed June 13, 2022.
   Google Scholar
• Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Supplement_7):S521–S528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• Breilh D, Texier-Maugein J, Allaouchiche B, et al. Carbapenems. J Chemother. 2013;25(1):1–17. doi:10.1179/1973947812Y.0000000032
   PubMed Web of Science ®Google Scholar
• Congeni BL. Ertapenem. Expert Opin Pharmacother. 2010;11(4):669–672. doi:10.1517/14656561003631397
   PubMed Web of Science ®Google Scholar
• Doumith M, Ellington MJ, Livermore DM, et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother. 2009;63(4):659–667. doi:10.1093/jac/dkp029
   PubMed Web of Science ®Google Scholar
• Chung H-S, Yong D, Lee M. Mechanisms of ertapenem resistance in enterobacteriaceae isolates in a tertiary university hospital. J Investig Med. 2016;64(5):1042–1049. doi:10.1136/jim-2016-000117
   PubMed Web of Science ®Google Scholar
• Jones RN, Sader HS, Fritsche TR. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms. Diagn Microbiol Infect Dis. 2005;52(1):71–74. doi:10.1016/j.diagmicrobio.2004.12.008
   PubMed Web of Science ®Google Scholar
• Teo J, Cai Y, Tang S, et al. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible enterobacteriaceae: a case-case-control study. PLoS One. 2012;7(3):e34254, doi:10.1371/journal.pone.0034254
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Mills DM, Chow N. Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(8):3203–3206. doi:10.1128/AAC.48.8.3203-3206.2004
   PubMed Web of Science ®Google Scholar
• Adelman MW, Bower CW, Grass JE, et al. Distinctive features of ertapenem-mono-resistant carbapenem-resistant enterobacterales in the United States: a cohort study. Open Forum Infect Dis. 2022;9(1):ofab643, doi:10.1093/ofid/ofab643
   PubMed Web of Science ®Google Scholar
• Wang D, Wang M, He T, et al. Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China. Front Microbiol. 2022;13:974990, doi:10.3389/fmicb.2022.974990
   PubMedGoogle Scholar
• Kocer K, Klein S, Hildebrand D, et al. Pitfalls in genotypic antimicrobial susceptibility testing caused by low expression of bla KPC in Escherichia coli. J Antimicrob Chemother. 2021;76(11):2795–2801. doi:10.1093/jac/dkab267
   PubMed Web of Science ®Google Scholar
• Lee N-Y, Yan J-J, Lee H-C, et al. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms. J Microbiol Immunol Infect. 2004;37(5):343–349.
   PubMedGoogle Scholar
• Weisenberg SA, Morgan DJ, Espinal-Witter R, et al. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis. 2009;64(2):233–235. doi:10.1016/j.diagmicrobio.2009.02.004
   PubMed Web of Science ®Google Scholar
• Paveenkittiporn W, Lyman M, Biedron C, et al. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018. Antimicrob Resist Infect Control. 2021;10(1):88, doi:10.1186/s13756-021-00950-7
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 31st ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Liu Z, Guan J, Chen Z, et al. CpxR promotes the carbapenem antibiotic resistance of Klebsiella pneumoniae by directly regulating the expression and the dissemination of blaKPC on the IncFII conjugative plasmid. Emerg Microbes Infect. 2023;12(2):2256427, doi:10.1080/22221751.2023.2256427
   PubMed Web of Science ®Google Scholar
• Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–2069. doi:10.1093/bioinformatics/btu153
   PubMed Web of Science ®Google Scholar
• Feldgarden M, Brover V, Gonzalez-Escalona N, et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci Rep. 2021;11(1):12728, doi:10.1038/s41598-021-91456-0
   PubMed Web of Science ®Google Scholar
• Tonkin-Hill G, MacAlasdair N, Ruis C, et al. Producing polished prokaryotic pangenomes with the Panaroo pipeline. Genome Biol. 2020;21(1):180, doi:10.1186/s13059-020-02090-4
   PubMed Web of Science ®Google Scholar
• Minh BQ, Schmidt HA, Chernomor O, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic Era. Mol Biol Evol. 2020;37(5):1530–1534. doi:10.1093/molbev/msaa015
   PubMed Web of Science ®Google Scholar
• Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293–W296. doi:10.1093/nar/gkab301
   PubMed Web of Science ®Google Scholar
• Altschup SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–410. doi:10.1016/S0022-2836(05)80360-2
   PubMed Web of Science ®Google Scholar
• Machuca J, López-Cerero L, Fernández-Cuenca F, et al. OXA-48-Like-Producing klebsiella pneumoniae in southern Spain in 2014–2015. Antimicrob Agents Chemother. 2019;63(1):e01396–18. doi:10.1128/AAC.01396-18
   PubMed Web of Science ®Google Scholar
• Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67(7):1597–1606. doi:10.1093/jac/dks121
   PubMed Web of Science ®Google Scholar
• Wei D-W, Wong N-K, Song Y, et al. Is26 veers genomic plasticity and genetic rearrangement toward carbapenem hyperresistance under sublethal antibiotics. mBio. 2022;13(1):e03340–21.
   Web of Science ®Google Scholar
• Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2023: ciad428.
   PubMedGoogle Scholar
• Livermore DM, Nicolau DP, Hopkins KL, et al. Carbapenem-Resistant enterobacterales, carbapenem resistant organisms, carbapenemase-producing enterobacterales, and carbapenemase-producing organisms: terminology past its “sell-By date” in an Era of New Antibiotics and Regional Carbapenemase Epidemiology. Clin Infect Dis. 2020;71(7):1776–1782.
   PubMed Web of Science ®Google Scholar
• Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis. 2010;23(4):327–331. doi:10.1097/QCO.0b013e32833b3571
   PubMed Web of Science ®Google Scholar